PCSK9-IN-20

Overview

PCSK9-IN-20 (Compound 3i) is a PCSK9 inhibitor with an IC 50 of 3.96 µM. PCSK9-IN-20 decreases PCSK9 and increases LDLR protein expression in vitro.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > PCSK9

Product Information

• Catalog No.: HY-155415
• CAS No.: 2929219-77-0
• Molecular Formula: C27H32N6O5S2
• Molecular Weight: 584.71
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source